| Code | 3523D | ||||||||||
| MA number | 24/0027/20-S | ||||||||||
| Product Form: | tbl 15x5 mg (blis.Al/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Glenmark Pharmaceuticals s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 24 - ANTIHISTAMINICA, HISTAMIN | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/Al |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 05.02.2020 |
| Validity: | 05.02.2025 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Desloratadine Glenmark 5 mg tablety_01_2023.pdf
|
| PIL: |
PIL_Desloratadine Glenmark 5 mg tablety_03/2024.pdf
|
| Safety feature | Yes |
| Data update: | 06.02.2020 |
